Individuals typically monitor appetite changes, digestive responses, weight patterns, and energy levels
At least, thats the take-home message of early clinical trial results released by Novo Nordisk, the drugs maker, on August 8
, ,
0.81g per pound of bodyweight
The goal isnt choosing one therapy over another but rather matching the right treatment to the right patient at the right time. This article has been updated with comments from one of the studys authors.
EP Edge Journal Watch Issue 13 (February/March 2026) : When the Signal Outruns the Rulebook (Ultrashort AF, ILR Truth, Metabolic Modulation & Next-Gen PFA Welcome backand thank you for being herefor EP Edge Journal Watch (Issue 13, February 2026) This issue of EP Edge Journal Watch tackles a problem we all recognize in 2026 EP: our signal detection (wearables, patches, ILRs) and our energy delivery (PFA variants) are advancing faster than the clinical rules we use to interpret risk and outcomes